[Special Stock] Samchundang Pharmaceutical Hits Upper Limit... Exclusive US Sales Contract with German Company
Samchundang Pharmaceutical has hit the upper price limit.
As of 10:48 AM on the 23rd, Samchundang Pharmaceutical was trading at 153,500 KRW on the KOSDAQ market, up 35,400 KRW (29.97%) from the previous trading day.
Hot Picks Today
![[Exclusive] "What? I Used It for Fried Eggs and Kimchi Pancakes, but It Wasn't Edible?"... Raw Pork Lard Supplied to Department Stores, Causing Stir](https://cwcontent.asiae.co.kr/asiaresize/93/2026042216151436513_1776842114.png)
[Exclusive] "What? I Used It for Fried Eggs and...
- [Breaking] Q1 GDP Surges 1.7%...Exceeds Forecasts
- After Cheongung's Success, Now It's 'Haegung'... First Export Achievement Worth ...
- Thought the Pandemic Was Over? Bat Virus Warns of Human Cell Infiltration Withou...
- [Report] "Professionals in Their 30s and 40s With at Least 2 Billion Won in Cash...
Samchundang Pharmaceutical recorded the upper price limit following news that it signed an exclusive sales contract with a German company for the Ailia biosimilar candidate substance in the United States and Central and South American countries.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
